20
Pharmacy and Drugs Act
Nc.12
2001
(a) details of the composition of the drug, and
(b) copies of any descriptive matter published or
proposed to be published in relation to the
drug.
(2) No disclosure of infonnation furnished under this section
shaH be made without the consent of the person by whom it was
furnished.
Power to
prohibit sale
of proprietary
drug.
34. (1) The Board may prohibit the sale of a proprietary drug if
in its opinion:
(a) claims are made for the drugs \vhich are
unjustified: or
(b) details of the composition of the drug furnished
under this Act differ substantially from those
disclosed on an analysis of samples by a
laboratory approved by the Board.
Descriptive matter published in relation toa propriet9rY
drug must be in English and should not differ substantially from that
contained in copies furnished to the Board in relation to ~e drug under
section 33 and the Board may prohi bi t the .sale of any drug, in respect
of which it is satisfIed that this subsectiorthas not been complied with.
(2)
Control of
publication of
deseri pti ve
matter.
lS.
(1) Subject to this section, no person shall, by way of
advertisement, publish or cause to be published in relation to any drug
or service, descriptive matter calculated to lead to the use of that drug
or servIce:
(a) for the prevention or treatment of anydisease
specified in the Second Schedule; or
(b) for the purpose of tenninating or influencing
the course of human pregnancy; or
(c) for any purpose relating to human sexual
intercourse.
I
l
I
f